Literature DB >> 20176896

Peptide fragments of a beta-defensin derivative with potent bactericidal activity.

Natalie L Reynolds1, Martin De Cecco, Karen Taylor, Chloe Stanton, Fiona Kilanowski, Jason Kalapothakis, Emily Seo, Dusan Uhrin, Dominic Campopiano, John Govan, Derek Macmillan, Perdita Barran, Julia R Dorin.   

Abstract

Beta-defensins are known to be both antimicrobial and able to chemoattract various immune cells. Although the sequences of paralogous genes are not highly conserved, the core defensin structure is retained. Defb14-1C(V) has bactericidal activity similar to that of its parent peptide (murine beta-defensin Defb14) despite all but one of the canonical six cysteines being replaced with alanines. The 23-amino-acid N-terminal half of Defb14-1C(V) is a potent antimicrobial while the C-terminal half is not. Here, we use a library of peptide derivatives to demonstrate that the antimicrobial activity can be localized to a particular region. Overlapping fragments of the N-terminal region were tested for their ability to kill Gram-positive and Gram-negative bacteria. We demonstrate that the most N-terminal fragments (amino acids 1 to 10 and 6 to 17) are potent antimicrobials against Gram-negative bacteria whereas fragments based on sequence more C terminal than amino acid 13 have very poor activity against both Gram-positive and -negative types. We further test a series of N-terminal deletion peptides in both their monomeric and dimeric forms. We find that bactericidal activity is lost against both Gram types as the deletion region increases, with the point at which this occurs varying between bacterial strains. The dimeric form of the peptides is more resistant to the peptide deletions, but this is not due just to increased charge. Our results indicate that the primary sequence, together with structure, is essential in the bactericidal action of this beta-defensin derivative peptide and importantly identifies a short fragment from the peptide that is a potent bactericide.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20176896      PMCID: PMC2863616          DOI: 10.1128/AAC.01568-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity.

Authors:  Enno Klüver; Sandra Schulz-Maronde; Svenja Scheid; Bernd Meyer; Wolf-Georg Forssmann; Knut Adermann
Journal:  Biochemistry       Date:  2005-07-19       Impact factor: 3.162

2.  A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon.

Authors:  Klaus Fellermann; Daniel E Stange; Elke Schaeffeler; Hartmut Schmalzl; Jan Wehkamp; Charles L Bevins; Walter Reinisch; Alexander Teml; Matthias Schwab; Peter Lichter; Bernhard Radlwimmer; Eduard F Stange
Journal:  Am J Hum Genet       Date:  2006-07-12       Impact factor: 11.025

3.  Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6.

Authors:  D Yang; O Chertov; S N Bykovskaia; Q Chen; M J Buffo; J Shogan; M Anderson; J M Schröder; J M Wang; O M Howard; J J Oppenheim
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

Review 4.  Human beta-defensins.

Authors:  M Pazgier; D M Hoover; D Yang; W Lu; J Lubkowski
Journal:  Cell Mol Life Sci       Date:  2006-06       Impact factor: 9.261

5.  Studies of the biological properties of human beta-defensin 1.

Authors:  Marzena Pazgier; Adam Prahl; David M Hoover; Jacek Lubkowski
Journal:  J Biol Chem       Date:  2006-10-27       Impact factor: 5.157

6.  Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3.

Authors:  Zhibin Wu; David M Hoover; De Yang; Cyril Boulègue; Fanny Santamaria; Joost J Oppenheim; Jacek Lubkowski; Wuyuan Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-02       Impact factor: 11.205

7.  Functional analysis of the alpha-defensin disulfide array in mouse cryptdin-4.

Authors:  Atsuo Maemoto; Xiaoqing Qu; K Johan Rosengren; Hiroki Tanabe; Agnes Henschen-Edman; David J Craik; Andre J Ouellette
Journal:  J Biol Chem       Date:  2004-08-05       Impact factor: 5.157

8.  Structure-activity relationships in defensin dimers: a novel link between beta-defensin tertiary structure and antimicrobial activity.

Authors:  Dominic J Campopiano; David J Clarke; Nick C Polfer; Perdita E Barran; Ross J Langley; John R W Govan; Alison Maxwell; Julia R Dorin
Journal:  J Biol Chem       Date:  2004-08-17       Impact factor: 5.157

9.  Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3.

Authors:  Giuseppantonio Maisetta; Mariagrazia Di Luca; Semih Esin; Walter Florio; Franca Lisa Brancatisano; Daria Bottai; Mario Campa; Giovanna Batoni
Journal:  Peptides       Date:  2007-10-24       Impact factor: 3.750

10.  The complexity of selection at the major primate beta-defensin locus.

Authors:  Colin A M Semple; Alison Maxwell; Philippe Gautier; Fiona M Kilanowski; Hayden Eastwood; Perdita E Barran; Julia R Dorin
Journal:  BMC Evol Biol       Date:  2005-05-18       Impact factor: 3.260

View more
  7 in total

Review 1.  Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?

Authors:  Nicole K Brogden; Kim A Brogden
Journal:  Int J Antimicrob Agents       Date:  2011-07-05       Impact factor: 5.283

2.  Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.

Authors:  Paulus H S Kwakman; Jeroen Krijgsveld; Leonie de Boer; Leonard T Nguyen; Laura Boszhard; Jocelyne Vreede; Henk L Dekker; Dave Speijer; Jan W Drijfhout; Anje A te Velde; Wim Crielaard; Hans J Vogel; Christina M J E Vandenbroucke-Grauls; Sebastian A J Zaat
Journal:  J Biol Chem       Date:  2011-10-24       Impact factor: 5.157

3.  Cytokeratins mediate epithelial innate defense through their antimicrobial properties.

Authors:  Connie Tam; James J Mun; David J Evans; Suzanne M J Fleiszig
Journal:  J Clin Invest       Date:  2012-09-24       Impact factor: 14.808

4.  Proteolytic Degradation of reduced Human Beta Defensin 1 generates a Novel Antibiotic Octapeptide.

Authors:  Judith Wendler; Bjoern O Schroeder; Dirk Ehmann; Louis Koeninger; Daniela Mailänder-Sánchez; Christina Lemberg; Stephanie Wanner; Martin Schaller; Eduard F Stange; Nisar P Malek; Christopher Weidenmaier; Salomé LeibundGut-Landmann; Jan Wehkamp
Journal:  Sci Rep       Date:  2019-03-06       Impact factor: 4.379

Review 5.  Antimicrobial Peptides as Anti-Infective Agents in Pre-Post-Antibiotic Era?

Authors:  Tomislav Rončević; Jasna Puizina; Alessandro Tossi
Journal:  Int J Mol Sci       Date:  2019-11-14       Impact factor: 5.923

6.  Human antimicrobial peptides and proteins.

Authors:  Guangshun Wang
Journal:  Pharmaceuticals (Basel)       Date:  2014-05-13

7.  Antimicrobial peptide-loaded liquid crystalline precursor bioadhesive system for the prevention of dental caries.

Authors:  Kelly Limi Aida; Paula Fernanda Kreling; Karina Sampaio Caiaffa; Giovana Maria Fioramonti Calixto; Marlus Chorilli; Denise Mp Spolidorio; Norival Alves Santos-Filho; Eduardo Maffud Cilli; Cristiane Duque
Journal:  Int J Nanomedicine       Date:  2018-05-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.